About Genoox
Genoox is a company based in Tel Aviv (Israel) founded in 2012 was acquired by Qiagen in May 2025. Genoox has raised $20 million across 4 funding rounds from investors including Qiagen, Triventures and Glilot. Genoox offers products and services including Franklin and Data Platform. Genoox operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genoox
Genoox offers a comprehensive portfolio of products and services, including Franklin and Data Platform.
Open platform for professionals to share and interpret genomic data insights.
System for fusing real-world evidence with public data for clinical applications.
People of Genoox
Unlock access to complete
Funding Insights of Genoox
Genoox has successfully raised a total of $20M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genoox
Genoox has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Qiagen, Triventures and Glilot.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in early stage healthcare startups
|
Locked | Locked | Locked | |
|
Limited information is provided about Glilot's activities.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Genoox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genoox
Investment portfolio details for Genoox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genoox
Detailed financials for Genoox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genoox Comparisons
Peer comparison for Genoox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genoox
Genoox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
Detailed competitors of Genoox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genoox
Complete news archive for Genoox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genoox
Genoox was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Genoox is headquartered in Tel Aviv, Israel.
Genoox is a funded company, having raised a total of $20M across 4 funding rounds to date.
Genoox was founded in 2012 in Tel Aviv, Israel, within the clinical genomics sector. A cloud-based platform is operated for storing and managing genomic data, supporting medical experts in delivering personalized treatments based on genetic and clinical information. Researchers are assisted in identifying genetic patterns and mutation similarities. Deep learning methods and compression algorithms are utilized to address storage and analysis challenges in clinical genomics.
Genoox's top competitors include Helix, Benchling and BioAge Labs.
Genoox offers Franklin and Data Platform.
Genoox has 6 investors. Key investors include Qiagen, Triventures, Glilot, Inimiti, and IN Venture.